Seeking Alpha

Drug developer Array BioPharma (ARRY -12.3%) slides after pricing an 18M share secondary...

Drug developer Array BioPharma (ARRY -12.3%) slides after pricing an 18M share secondary offering at $3.65 per share, a 10% discount to yesterday's close. The company had 95.4M shares outstanding as of October, which would make the sale nearly a 19% dilution to its float.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|